Response Genetics Stock Working Capital
| RGDXQ Stock | USD 0.0001 0.00 0.00% |
Response Genetics' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Response Pink Sheet price.
Response |
Response Genetics Company Working Capital Analysis
Response Genetics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Response Genetics Working Capital | 3.88 M |
Most of Response Genetics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Response Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Response Genetics has a Working Capital of 3.88 M. This is 99.09% lower than that of the Life Sciences Tools & Services sector and 99.16% lower than that of the Health Care industry. The working capital for all United States stocks is 99.74% higher than that of the company.
Response Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Response Genetics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Response Genetics could also be used in its relative valuation, which is a method of valuing Response Genetics by comparing valuation metrics of similar companies.Response Genetics is currently under evaluation in working capital category among its peers.
Response Fundamentals
| Return On Asset | -0.68 | |||
| Profit Margin | (0.86) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 9.24 M | |||
| Shares Outstanding | 38.8 M | |||
| Number Of Shares Shorted | 78.1 K | |||
| Revenue | 18.04 M | |||
| Gross Profit | 6.23 M | |||
| EBITDA | (19.36 M) | |||
| Net Income | (20.18 M) | |||
| Cash And Equivalents | 1.73 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 10.94 M | |||
| Current Ratio | 1.79 X | |||
| Book Value Per Share | (0.13) X | |||
| Cash Flow From Operations | (13.6 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Target Price | 1.8 | |||
| Number Of Employees | 96 | |||
| Beta | 2.09 | |||
| Market Capitalization | 116 | |||
| Total Asset | 48.88 M | |||
| Retained Earnings | (83.02 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 8.76 M | |||
| Current Liabilities | 4.88 M | |||
| Z Score | -1.4 | |||
| Net Asset | 48.88 M |
About Response Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Response Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Response Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Response Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Response Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Response Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Response Genetics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Response Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Response Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Response Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Response Genetics to buy it.
The correlation of Response Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Response Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Response Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Response Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Response Pink Sheet Analysis
When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.